Evaluating the neuroprotective impact of senolytic drugs on human vision

Glaucoma, a chronic neurodegenerative disease of retinal ganglion cells (RGCs), is a leading cause of irreversible blindness worldwide. Its management currently focuses on lowering intraocular pressure to slow disease progression. However, disease-modifying, neuroprotective treatments for glaucoma r...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Nimri, Nevin W., Moore, Spencer M., Zangwill, Linda M., Proudfoot, James A., Weinreb, Robert N., Skowronska-Krawczyk, Dorota, Baxter, Sally L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730173/
https://www.ncbi.nlm.nih.gov/pubmed/33303874
http://dx.doi.org/10.1038/s41598-020-78802-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730173/
https://www.ncbi.nlm.nih.gov/pubmed/33303874
http://dx.doi.org/10.1038/s41598-020-78802-4

Ejemplares similares